NCT05275478 2026-04-15
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Phase 1/2 Terminated
Tango Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Centre Oscar Lambret
Wake Forest University Health Sciences
The Netherlands Cancer Institute